Full index of posts »
Latest Followers
StockTalks
-
is the market correction here? and if so how big of a correction to expect? - 10, 15, 20%?? Feb 4, 2013
-
would you rather borrow $10K for a year at 2% or at 4.5% for 2 years??? Nov 5, 2012
-
opened a position in drillcon today. small cap with good fundamentals: http://www.drillcon.se Sep 11, 2012
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
View phillyslick's Instablogs on:
Diamond Core Driller In The Rough: Drillcon AB
Drillcon AB (DRIL.STO) is a swedish-based company specializing in diamond core drilling and raise boring.
It is a small-cap company listed on the NASDAQ OMX First North market.
Drillcon AB currently trades at 4.7 SEK per share, has a price to earnings ratio (P/E) of 6.4 and has a dividend yield of 3%.
The largest shareholder of Drillcon (a pension fund) holds 5.5% of the outstanding shares.
Drillcon AB is growing its revenue, income and dividend and has a solid cash flow.
Vitrolife: A Small-cap With Potential
Sales have increased for 36 consecutive quarters and have grown ~75% since 2006. Over the same period, net income doubled.
The current p/e is ~27 and dividend yield is ~1.3%.
Vitrolife specializes in 3 areas: in vitro fertilization, stem cell therapy and transplantations. They have access to US, European, Middle-east and Asian markets.
As of Dec. 2011, JP Morgan was one of the top 10 investors in Vitrolife.
Other information (from: http://www.news-medical.net/news/20120207/Vitrolife-fourth-quarter-sales-increase-1825-to-SEK-95-million.aspx )
-- Vitrolife was the first company to obtain regulatory approval in China for a whole series of cultivation media for IVF
-- A study showed that EmbryoGlue®, a product patented by Vitrolife, increases the chances of infertile women having children.
-- A clinical study showing good results when using STEEN Solution™ was published in a prominent scientific journal. In all more than 100 patients have now received new lungs through the use of STEEN Solution™.
As an investor with a strong background in the medical sciences, I believe Vitrolife is taking a smart approach to addressing the challenges of in vitro fertilization, stem cell therapy and transplantations. Thus, I would argue Vitrolife is a good investment with long-term potential.
I am long Vitrolife
t-testing the Case-Shiller
I downloaded the Case-Shiller excel file and ran paired t-tests comparing the results of 20 cities from February, March, April, and May of 2010.
Here's the results (mean value):
February (133.2) v. March (133.1); p > 0.05
March (133.1) v. April (134.0); p < 0.001
April (134.0) v. May (134.5); p = 0.011
In conclusion, the Case-Shiller index has been rising since March and it is very unlikely that this is due to chance... Average house prices in these 20 cities are significantly rising.
Disclosure: No positions in US housing